Asia Pacific Malaria Treatment Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Treatment (Generic Drugs, Originators, Vaccines, and Others), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

No. of Pages: 88
Report Code: TIPRE00025037
Category: Life Sciences
Asia Pacific Malaria Treatment Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Malaria Treatment Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Malaria Treatment Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Malaria Treatment Market Regional Analysis

6.2 Asia Pacific Malaria Treatment Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Malaria Treatment Market Forecast Analysis

7. Asia Pacific Malaria Treatment Market Analysis – by Treatment

7.1 Generic Drugs
  • 7.1.1 Overview
  • 7.1.2 Generic Drugs: Asia Pacific Malaria Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Originators
  • 7.2.1 Overview
  • 7.2.2 Originators: Asia Pacific Malaria Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Vaccines
  • 7.3.1 Overview
  • 7.3.2 Vaccines: Asia Pacific Malaria Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Asia Pacific Malaria Treatment Market Analysis – by Route of Administration

8.1 Oral
  • 8.1.1 Overview
  • 8.1.2 Oral: Asia Pacific Malaria Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Parenteral
  • 8.2.1 Overview
  • 8.2.2 Parenteral: Asia Pacific Malaria Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Asia Pacific Malaria Treatment Market Analysis – by Distribution Channel

9.1 Direct Tender
  • 9.1.1 Overview
  • 9.1.2 Direct Tender: Asia Pacific Malaria Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Hospital Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Hospital Pharmacies: Asia Pacific Malaria Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Retail Pharmacies
  • 9.3.1 Overview
  • 9.3.2 Retail Pharmacies: Asia Pacific Malaria Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Online Pharmacies
  • 9.4.1 Overview
  • 9.4.2 Online Pharmacies: Asia Pacific Malaria Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Asia Pacific Malaria Treatment Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific
  • 10.2.1 Asia Pacific Malaria Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.2.1.1 Asia Pacific Malaria Treatment Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 China: Asia Pacific Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.1.1 China: Asia Pacific Malaria Treatment Market Breakdown, by Treatment
    • 10.2.1.1.2 China: Asia Pacific Malaria Treatment Market Breakdown, by Route of Administration
    • 10.2.1.1.3 China: Asia Pacific Malaria Treatment Market Breakdown, by Distribution Channel
  • 10.2.1.2 India: Asia Pacific Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.2.1 India: Asia Pacific Malaria Treatment Market Breakdown, by Treatment
    • 10.2.1.2.2 India: Asia Pacific Malaria Treatment Market Breakdown, by Route of Administration
    • 10.2.1.2.3 India: Asia Pacific Malaria Treatment Market Breakdown, by Distribution Channel
  • 10.2.1.3 Japan: Asia Pacific Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.3.1 Japan: Asia Pacific Malaria Treatment Market Breakdown, by Treatment
    • 10.2.1.3.2 Japan: Asia Pacific Malaria Treatment Market Breakdown, by Route of Administration
    • 10.2.1.3.3 Japan: Asia Pacific Malaria Treatment Market Breakdown, by Distribution Channel
  • 10.2.1.4 Australia: Asia Pacific Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.4.1 Australia: Asia Pacific Malaria Treatment Market Breakdown, by Treatment
    • 10.2.1.4.2 Australia: Asia Pacific Malaria Treatment Market Breakdown, by Route of Administration
    • 10.2.1.4.3 Australia: Asia Pacific Malaria Treatment Market Breakdown, by Distribution Channel
  • 10.2.1.5 Rest of Asia-Pacific : Asia Pacific Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Malaria Treatment Market Breakdown, by Treatment
    • 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Malaria Treatment Market Breakdown, by Route of Administration
    • 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Malaria Treatment Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Cipla Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Sun Pharmaceutical Industries Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Sanofi SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 GSK Plc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Novartis AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Pfizer Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 AdvaCare Pharma USA LLC
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Lupin Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Asia Pacific Malaria Treatment Market

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • AdvaCare Pharma USA LLC
  • Lupin Ltd
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)